Vol. 39 No. 5 (2022): OCTUBRE
Laboratory and Infectious Diseases

Phenotypic and molecular characterization of OXA-48 like producing Klebsiella pneumoniae isolates in Chile

Ingrid Araya
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Freddy Roach-Poblete
Hospital Regional de Antofagasta Dr. Leonardo Guzmán
Bio
Teresa Tapia
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Paula I. Rodas
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Aura Villamil
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Rocio Aguero
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Rodrigo Iglesias
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Diego Garate
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Oscar Duery
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Roberto Flores
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Daniel Ibañez
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Jorge Fernandez
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Pamela Araya
INSTITUTO DE SALUD PÚBLICA ISP
Bio
Mauro Orsini
División de Gestión de la Red Asistencial, Subsecretaría de Redes Asistenciales
Bio
Juan Carlos Hormazábal
INSTITUTO DE SALUD PÚBLICA ISP
Bio

Published 2022-11-27

How to Cite

1.
Araya I, Roach-Poblete F, Tapia T, Rodas PI, Villamil A, Aguero R, Iglesias R, Garate D, Duery O, Flores R, Ibañez D, Fernandez J, Araya P, Orsini M, Hormazábal JC. Phenotypic and molecular characterization of OXA-48 like producing Klebsiella pneumoniae isolates in Chile. Rev. Chilena. Infectol. [Internet]. 2022 Nov. 27 [cited 2026 Mar. 26];39(5). Available from: https://revinf.cl/index.php/revinf/article/view/1280

Abstract

Background: The appearance and spread of carbapenems-resistant Enterobacterales have generated a major impact on health care-associated infections worldwide. Recently, a Klebsiella pneumoniae outbreak expressing OXA-48 like-carbapenemases was detected in Chile, the first reported cases corresponded to hospitalized patients mainly from northern Chile. Aim: To characterize the phenotypic and genotypic profiles of antimicrobial susceptibility of 16 clinical isolates referred during May 2021 from Antofagasta and Metropolitan regions to the Reference Laboratory of Instituto de Salud Publica. Methods: Antimicrobial susceptibility of all strains was analyzed using traditional (Kirby-Bauer and epsilometry) and automated methods, and complemented with colorimetric, immunochromatographic and molecular (PCR and PFGE) techniques. As a result of the genetic characterization, blaoxa-48 and blaoxa-232 genes were detected, showing the isolates an unusual resistance profile to both carbapenems (ertapenem, imipenem, and meropenem) and cephalosporins (cefepime, cefotaxime, and ceftazidine), as well as piperacillin/tazobactam and temocillin. Two subtypes were detected by PFGE, with a predominant clone CL-Kpn-Spe-329 (93.8%), with two resistance mechanisms identified: carbapenemase and extended-spectrum b-lactamase (ESBL). Conclusion: Due to this epidemiological alert, it is essential the establishment of national guidelines for early detection, surveillance, and control of future outbreaks of OXA-48 like carbapenemases isolates.